Exenatide Delays Gastric Emptying in Patients with Type 2 Diabetes Mellitus but not in Those with Gastroparetic Conditions
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The effect of the treatment with glucagon-like peptide (GLP)-1 receptor agonists on gastric emptying in patients with diabetes with and without gastroparesis is analysed. Patients with type 2 diabetes mellitus subjected to GLP-1 receptor agonist therapy with exenatide were examined before and shortly after initiation of treatment. Gastric half-emptying time was determined by 13C-octanoic breath test; routine laboratory parameter as well as active GLP-1, ghrelin, leptin, insulin, proinsulin and C-peptide levels were determined in fasting state as well as postprandial secretion within 1 h after a standardised meal. Thirty patients’ data sets were available for evaluation, of those 20 patients had no gastroparesis and 10 patients showed pathological results following the breath test. Gastric half-emptying time was prolonged in nearly all patients who presented without gastroparesis at initiation of treatment with GLP-1 receptor agonists, only 2 patients with pre-existing mild gastroparesis had worsening of gastric emptying. No effect was detected on leptin and ghrelin levels. Postprandial GLP-1 concentrations measured as AUC after meal decreased significantly. Fasting insulin and C-peptide levels increased significantly without effect on postprandial levels. Proinsulin levels – fasting as well as AUC – decreased non-significantly. Patients reported comparable perception of therapeutic effects. Treatment with GLP-1 receptor agonists may be applied in patients with pre-existing gastroparesis; no effect in terms of worsening of symptoms compared to those without gastroparesis was detected. Patients reported outcome was independent from underlying gastroparesis. Negative effects on gastric emptying were only detected in patients without or with mild gastroparesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exenatide prolonged the gastric half-emptying time in all diabetic patients without gastroparesis (n = 20) and worsened the gastric emptying in two of ten diabetics with pre-existing mild gastroparesis [56].”
From Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review (2024) · cites this paper as [56]
Citations
Cites
(1992) · PubMed · Cited by 33,716
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
Ghoos, Y. F., Maes, B. D., Geypens, B. J., Mys, G., Hiele, M. I., Rutgeerts, P. J., & Vantrappen, G. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90640-x · Cited by 946
Soykan, I., Sivri, B., Sarosiek, I., Kiernan, B., & Mccallum, R. W. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026665728213 · Cited by 575 · cited 1×
“Etiologically, 29 % of gastroparesis is related to diabetes, 36 % is idiopathic, 13 % is due to post-gastric surgery and the remaining is associated to neurodegenerative diseases, collagen vascular disorder and intestinal pseudo-obstruction [5].”
BackgroundAssessing Impact of Weight on Quality of Life
Kolotkin, R. L., Head, S., Hamilton, M., & Tse, C. J. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00120.x · Cited by 334
Gastric emptying in diabetes: clinical significance and treatment
Horowitz, M., O’Donovan, D., Jones, K. L., Feinle, C., Rayner, C. K., & Samsom, M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00658.x · Cited by 308 · cited 2×
“The prevalence of gastroparesis in patients with long standing diabetes has been estimated at 30–50 % [2].”
BackgroundEpidemiology, mechanisms, and management of diabetic gastroparesis
Camilleri, M., Bharucha, A. E., & Farrugia, G. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.09.022 · Cited by 287
Nitric oxide in gastrointestinal health and disease
Shah, V., Lyford, G., Gores, G., & Farrugia, G. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.046 · Cited by 267
Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting
parkman, H. P., camilleri, M., farrugia, G., mccallum, R. W., bharucha, A. E., mayer, E. A., tack, J. F., spiller, R., horowitz, M., vinik, A. I., et al. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01434.x · Cited by 192
Cited by
Goldney, J., Sargeant, J. A., & Davies, M. J. (2023) · Diabetologia · doi:10.1007/s00125-023-05988-3 · Cited by 100
Oprea, A. D., Ostapenko, L. J., Sweitzer, B., Selzer, A., Irizarry-Alvarado, J. M., Hurtado Andrade, M. D., Mendez, C. E., Kelley, K. D., Stewart, E., Fernandez Robles, C. R., et al. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.04.001 · Cited by 104
Calvarysky, B., Dotan, I., Shepshelovich, D., Leader, A., & Cohen, T. D. (2024) · Drug Safety · doi:10.1007/s40264-023-01392-3 · Cited by 97
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Heinla, K., Vasar, E., Reppo, I., Sedman, T., & Volke, V. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01381-w · Cited by 30
Ghazanfar, H., Javed, N., Qasim, A., Sosa, F., Altaf, F., Khan, S., Mahasamudram, J., Jyala, A., Kandhi, S. D., Shin, D., et al. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i26.3221 · Cited by 23
Metadata
- Authors
- Beti, C., Stratmann, B., Bokman, G., Dreier, J., Hauber, M., Lee-Barkey, Y., Fischer, M., Knabbe, C., & Tschoepe, D.
- Affiliations
- Heart and Diabetes Center North Rhine-Westphalia (DE)
- Corresponding author
- Tschoepe, Diethelm
- Venue
- Hormone and Metabolic Research
- Publisher
- Georg Thieme Verlag KG
- Published
- 2019-01-28
- Volume
- 51
- Issue
- 04
- Pages
- 267-273
- ISSN
- 0018-5043 (ISSN-L)
- 1439-4286
- OpenAlex
- W2913797456
- Cited by
- 15
- References
- 21
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 7 · 2023: 2 · 2022: 2
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hormone and Metabolic Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- exenatide, gastric emptying, type 2 diabetes, gastroparesis, GLP-1 receptor agonists, 13C-octanoic acid breath test, ghrelin, leptin, proinsulin, C-peptide, insulin
- MeSH terms
- Exenatide, Breath Tests, Diabetes Mellitus, Type 2, Female, Gastric Emptying, Humans, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Cohort Studies, Patient Satisfaction, Gastroparesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exenatide Delays Gastric Emptying in Patients with Type 2 Diabetes Mellitus but not in Those with Gastroparetic Conditions. https://app.cochat.ai/papers/10.1055/a-0818-6374
- The paper
- Beti, C., Stratmann, B., Bokman, G., Dreier, J., Hauber, M., Lee-Barkey, Y., Fischer, M., Knabbe, C., & Tschoepe, D. (2019). Exenatide Delays Gastric Emptying in Patients with Type 2 Diabetes Mellitus but not in Those with Gastroparetic Conditions. Hormone and Metabolic Research. https://doi.org/10.1055/a-0818-6374
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.